DC
GNMK

Deere & Company’s GenMark Diagnostics, Inc GNMK Stock Holding History

Deere & Company’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-22,488
Closed -$202K – 1095
2014
Q3 		$202K Hold
22,488
– – 0.01% 877
2014
Q2 		$304K Sell
22,488
-19,763
-47% -$206K 0.02% 740
2014
Q1 		$420K Buy
42,251
+22,698
+116% +$282K 0.02% 666
2013
Q4 		$260K Hold
19,553
– – 0.01% 807
2013
Q3 		$237K Buy
+19,553
New +$210K 0.01% 821

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deere & Company's GNMK Position: Q4 2014 in Review

Deere & Company sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2014, closing a stake of 22,488 shares — an estimated $202K sold.

Deere & Company first reported a position in GNMK in Q3 2013 and held it in 5 quarters. The position peaked at $420K in Q1 2014. 79 funds tracked by Wall St. Rank hold GNMK as of Q4 2014.

  • Deere & Company reported no remaining GenMark Diagnostics, Inc position as of Q4 2014 after selling out during the quarter.
  • Deere & Company sold 22,488 GenMark Diagnostics, Inc shares in Q4 2014, an estimated $202K.
  • Deere & Company first reported a position in GenMark Diagnostics, Inc in Q3 2013 and held it in 5 quarters.
  • Deere & Company's GenMark Diagnostics, Inc position peaked at $420K in Q1 2014.
  • 79 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2014.

Based on Deere & Company's 13F filing for Q4 2014, filed 12 Feb 2015.